An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
Clinical trial NCT01678690 · COMPLETED
Trial details
- NCT number
- NCT01678690
- Sponsor
- InnoPharmax Inc.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-04-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.